Norfo Antibiotic Private Limited
About Norfo Antibiotic Private Limited
Data last updated:
Norfo Antibiotic Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74990TG2017PTC114086. Its GSTIN is 10AAFCN4593D2ZQ (Bihar). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Manish Kumar and Priyanka Jha.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O – Sunil Kumar Jha 3 – 14 – 36/10/225 Street No.10 Vivek Nagar Ramanthapur, Hyderabad, Telangana, India – 500013.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.74 Lakh, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹41,182 (net margin -0.8%) and EBITDA of -₹28,393 (EBITDA margin -0.6%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 49% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Norfo Antibiotic Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O – Sunil Kumar Jha 3 – 14 – 36/10/225 Street No.10 Vivek Nagar Ramanthapur, Hyderabad, Telangana, India – 500013
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Norfo Antibiotic Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Norfo Antibiotic is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Norfo Antibiotic Private Limited, buy the company report.
Financials of Norfo Antibiotic Private Limited
FY 2024 filings availableNorfo Antibiotic Private Limited reported revenue of ₹50.74 Lakh (down 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 22% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 49%. EBITDA fell 111% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹28,393 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹41,182 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.6% | ||||
| Net Profit Margin | -0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Norfo Antibiotic Private Limited, buy the company report.
Board of directors of Norfo Antibiotic Private Limited
Norfo Antibiotic has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Kumar | Director | 17 Jan 2017 | 9 Years 9 Months | Current |
| Priyanka Jha | Director | 01 Dec 2020 | 5 Years 11 Months | Current |
Peer comparison
Norfo Antibiotic Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Markecho Pharmaceuticals Private Limited | ₹50.83 Lakh (FY 2024) | 17.0% | Andheri, Mumbai, Maharashtra, India | |||
| Endear Pharma Private Limited | ₹50.81 Lakh (FY 2021) | 347.0% | Bijnor, Uttar Pradesh, India | |||
| Blismed Pharmaceuticals Private Limited | ₹50.79 Lakh (FY 2025) | -4.0% | Baddi, Himachal Pradesh, India | |||
| Norfo Antibiotic Private Limitedthis company | ₹50.74 Lakh (FY 2025) | -₹41,182 | -0.8% | -22.0% | Hyderabad, Telangana, India | |
| Lucan Pharmaceuticals Private Limited | ₹50.57 Lakh (FY 2023) | 114.0% | Delhi, India |
To see the full peer comparison of Norfo Antibiotic Private Limited, buy the company report.
Auditor
Norfo Antibiotic Private Limited is audited by SINGH & THAKUR for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SINGH & THAKUR | FY 2022 | 024623N |
Shareholding
The shareholding of Norfo Antibiotic Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Norfo Antibiotic Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Norfo Antibiotic Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Norfo Antibiotic Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Norfo Antibiotic has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAFCN4593D2ZQ | Bihar | Active | 01 Feb 2018 |
To see the full GST registrations and return filing status of Norfo Antibiotic Private Limited, buy the company report.
Recent activity
Norfo Antibiotic Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Praveen Kumar Jha ceased to be Director on 01 Dec 2020.
Frequently asked questions
Norfo Antibiotic is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 January 2017 (9+ years old) and is registered under CIN U74990TG2017PTC114086.
Norfo Antibiotic has 2 current directors:
- Manish Kumar - Director
- Priyanka Jha - Director
The latest financial statements of Norfo Antibiotic on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Norfo Antibiotic is 10AAFCN4593D2ZQ, registered in Bihar. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Norfo Antibiotic is U74990TG2017PTC114086. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Norfo Antibiotic was incorporated on 17 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Norfo Antibiotic by revenue are Markecho Pharmaceuticals Private Limited, Endear Pharma Private Limited, Blismed Pharmaceuticals Private Limited, Lucan Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Praveen Kumar Jha ceased to be Director on 01 Dec 2020. Priyanka Jha was appointed as Director on 01 Dec 2020. Manish Kumar was appointed as Director on 17 Jan 2017.
The registered office of Norfo Antibiotic is at CO – Sunil Kumar Jha 3 – 14 – 3610225 Street No.10 Vivek Nagar Ramanthapur, Hyderabad, Telangana, India – 500013.
Norfo Antibiotic operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Norfo Antibiotic is compliant as of 17 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
